David Guiliano


Head of Bioscience

, School of Health, Sport and Bioscience

As Head of Department Dr Guiliano oversees the delivery and growth of a variety of undergraduate and postgraduate courses within the Biosciences. In addition, to managing the department he is also actively engaged in teaching, research, and supervising post-graduate students. He also chairs the School's Health and Safety committee and is head link for academic partnerships.


  • PhD
  • FHEA

Areas Of Interest

  • Immunology
  • Microbiology
  • Parasitology
  • Vaccine Development
  • Novel Therapeutic Strategies


David Guiliano
On This Page


Dr David Guiliano is the Head of the Department of Bioscience in the School of Health Sport and Bioscience (HSB) at UEL. 

He completed his PhD in Molecular Parasitology and Genomics in the Institute of Cell Animal and Population Biology at the University of Edinburgh in 2002. After completing his PhD. he held post-doctoral research appointments and research fellowships in various institutions including the School of Medicine at UCL and the Immunology Unit in the London School of Hygiene and Tropical Medicine. He was also awarded a Wellcome trust advanced training fellowship which he completed in the Deptartment of Biological Sciences at Imperial College London. 

Dr. Guiliano joined the UEL Bioscience faculty in 2011 and has held a number of positions within the school including course leader for the BSc Biomedical Science course, Research Degrees Leader, head link for academic partnerships, chair of the HSB Health and Safety Committee and subject head in Bioscience. He became the Head of Department for Bioscience in 2017.

External roles

Tier 1 and Tier 2 external examiner at Middlesex University


Dr Guiliano's research focuses on identifying novel intervention strategies for infectious diseases including rational drug and vaccine design for combating antimicrobial resistance in bacteria and parasites.

His group is currently focused on mining genome data of these organisms utilizing in silico modeling and drug docking software to assist in the  isolation of novel drugable targets. He part of an international collaborative effort to develop a mucosal vaccination system using transgenic probiotic organisms to deliver vaccinogens and accessory immuno-stimuli to the gastrointestinal mucosa. He is also interested in understanding the mechanisms by which pathogens dysregulate or avoid immune responses.  Currently his group is characterizing the activities of immuno-modulatory proteins secreted by gastrointestinal pathogens as many of these organisms occupy intracellular niches and utilize secreted effector molecules to both subvert the biology of the cells they infect and their host's immune responses. In particular they are focused on elucidating the activities of parasite cytokine homologues derived from the parasitic nematode Trichinella spiralis on epithelial and antigen presenting cells and other secreted proteins in the transformation of skeletal muscle into nurse cells.

Dr Guiliano is a member of the Infection and Immunity research group within HSB.

Most recent research

Some of Dr. Guiliano's most recent publications have focused on novel vaccine development in the parasitic nematode Trichinella spiralis (Srey et al. 2020) and development of novel biopharmaceuticals (Collins et al. 2021). 


Along with his research activities and duties as Head of Department, Dr Guiliano also teaches on a variety of modules within the undergraduate and post-graduate programs focusing on molecular biology, cancer, microbiology, parasitology, vaccinology, immunology, and infectious disease control.

Dr Guiliano became a Fellow of the Higher Education Authority in 2013 and is a Fellow of the Institute of Biomedical Sciences. He is a member of the British Society for Immunology, Society for Applied Microbiology, Society for General Microbiology and Biochemical Society.